A new mechanism to explain benign prostatic hyperplasia
Benign prostatic hyperplasia (BPH), a non-cancerous enlargement of the prostate, affects about half the men between 51 and 60 years of age, and nine out
Read More
Search Results for: prostate cancer
New class of small molecule, SI-2, can drug the ‘undruggable’ steroid receptor coactivator-3
By Ana María Rodríguez, Ph.D. Steroid receptor coactivator-3, which is well-known for its role in cancer formation and proliferation, is usually considered ‘undruggable’ because this nuclear
Read More
High throughput microscopy zeroes in on new estrogen receptor regulator
A high throughput microscopy technique enabled Baylor College of Medicine researchers to identify a new modulator of estrogen receptor alpha that they called UBR5. It
Read More